: Incorporates the newest systemic therapy algorithms, combining immunotherapy doublets as first-line treatments.
Algorithms for acute abdominal pain, dyspepsia, obscure GI bleeding, and jaundice.
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease provides several benefits to healthcare professionals, including:
Navigating Modern Gastroenterology: A Deep Dive into Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 12th Edition s gastrointestinal and liver disease 12th edition
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
: New coverage of AI applications in endoscopy to enhance the detection of gastrointestinal cancers. COVID-19 Impact
The 12th Edition is a two-volume set available in both hardcover and digital formats. : ~20,750 INR Elsevier Shop : Includes an eBook version with purchase DNA Mart : ~20,999 INR For medical advice or diagnosis, consult a professional
Ultimately, the 12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease reinforces its status as an essential cornerstone library addition for anyone dedicated to the care of patients with digestive and hepatic illnesses.
: Reviewers appreciate the consistent, templated format which allows for rapid information retrieval during clinical rounds.
| | Detail | | :--- | :--- | | Full Title | Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management | | Edition | 12th | | Publication Date | December 2025 | | Copyright Year | 2026 | | Page Count | 2,488 pages | | Print ISBN-13 | 978-0-443-11657-5 | | Print ISBN-10 | 0-443-11657-1 | | eBook ISBN-13 | 978-0-443-11727-5 | | Publisher | Elsevier Health Sciences | | Language | English | | Illustrations | Over 1,100 full-color illustrations | COVID-19 Impact The 12th Edition is a two-volume
Sleisenger and Fordtran's Gastrointestinal and Liver Disease - 2 Volume Set - 12th Edition | Elsevier Shop
: Expanded array of new biological treatments and small molecules. US Elsevier Health Enhanced Clinical Utility Editorial Leadership
, scheduled for release in , is a comprehensive two-volume masterwork that serves as the definitive reference for gastroenterology and hepatology. Key Highlights of the 12th Edition
The boundaries between minimally invasive surgery and gastroenterology continue to blur. This edition provides extensive coverage of cutting-edge interventional endoscopic procedures, including: